Quarterly report pursuant to Section 13 or 15(d)

Joint Venture and Options Transaction (Details)

v3.21.2
Joint Venture and Options Transaction (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 14, 2021
Mar. 01, 2020
Oct. 31, 2018
Aug. 31, 2021
Aug. 31, 2020
Feb. 28, 2021
May 31, 2021
May 31, 2020
Joint Venture and Options Transaction (Details) [Line Items]                
Financing Receivable, after Allowance for Credit Loss, Current $ 3,000,000   $ 5,000,000          
Note Receivable, Interest Rate, Stated Percentage     6.00%          
Interest Costs Capitalized       $ 0 $ 212,601      
Proceeds from Collection of Notes Receivable       1,174,082 $ 750,000      
Asset Impairment Charges           $ 2,498,706 $ 2,498,706  
In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Business Combination, Consideration Transferred     $ 47,500,000          
Payments to Acquire Businesses, Gross     35,000,000          
Business Combination, Consideration Transferred, Liabilities Incurred     7,500,000          
Financing Receivable, after Allowance for Credit Loss, Current       1,833,333     0  
Interest Income, Related Party             149,972 $ 296,450
Interest Costs Capitalized   $ 399,453         0 399,453
Proceeds from Collection of Notes Receivable       1,174,082   1,696,765   1,425,000
Option Agreement, Brake-Up Fee     $ 2,500,000          
Interest Rate, Default     15.00%          
In Good Health [Member] | Due And Payable On Or Before June 21, 2021 [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable 500,000              
In Good Health [Member] | Due And Payable On Or Before July 12, 2021 [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable 500,000              
In Good Health [Member] | Due And Payable In12 Monthly Installments [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable 2,000,000              
Payments to Acquire Notes Receivable $ 2,000,000              
Joint Venture with CannAssist [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Interest Receivable, Current             $ 0  
Principal [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable       1,166,667   1,544,291   1,357,278
Asset Impairment Charges           2,497,884    
Accrued Interest [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable       $ 7,415   152,473   $ 67,722
Asset Impairment Charges           $ 822    
Option Agreement [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Business Combination, Consideration Transferred     $ 47,500,000          
Payments to Acquire Businesses, Gross     35,000,000          
Business Combination, Consideration Transferred, Liabilities Incurred     7,500,000          
Business Combination, Consideration Transferred, Other     $ 2,500,000          
Debt Instrument, Term     5 years          
Restricted Stock [Member] | Option Agreement [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Equity Issued in Business Combination, Fair Value Disclosure     $ 5,000,000